Haqq Christopher

EVP, R&D & Chief Scientific Of at ATRA

Sold, on record
$7.6M
Dollars the filings state
Form 4 sales
34
Latest Feb 15, 2019
Form 144 notices
0
Proposed sales
Quarters with a sale
0 of the last 8
No sale in two years
Companies
1
Filed as an executive or holder

Companies

  • ATRAAtara Biotherapeutics, Inc.EVP, R&D & Chief Scientific Of

Sales by reason

0
Routine
29
Plan not stated
0
No plan
5
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per year, every sale on record.

Sales chart range

Timeline

  1. Feb 15, 2019Plan not stated

    ATRA

    Sold 0.3% of their holdings

    $31k775 shares at $39.59

    Filed Feb 19, 2019Form 4

  2. Feb 11, 2019Plan not stated

    ATRA

    Sold 4.9% of their holdings

    $539k13,975 shares at $38.55

    Filed Feb 11, 2019Form 4

  3. Feb 6, 2019Plan not stated

    ATRA

    Sold 4.3% of their holdings

    $478k12,375 shares at $38.62

    Filed Feb 8, 2019Form 4

  4. Nov 15, 2018Plan not stated

    ATRA

    Sold 0.3% of their holdings

    $26k775 shares at $33.81

    Filed Nov 15, 2018Form 4

  5. Sep 26, 2018Plan not stated

    ATRA

    Sold 4.5% of their holdings

    $582k13,500 shares at $43.08

    Filed Sep 27, 2018Form 4

  6. Sep 25, 2018Unusual

    ATRA

    Sold 9.5% of their holdings

    $1.3M31,500 shares at $40.17

    Filed Sep 25, 2018Form 4

  7. Aug 15, 2018Plan not stated

    ATRA

    Sold 0.2% of their holdings

    $29k775 shares at $37.54

    Filed Aug 16, 2018Form 4

  8. May 15, 2018Unusual

    ATRA

    Sold 7.2% of their holdings

    $1.2M25,775 shares at $45.30

    Filed May 16, 2018Form 4

  9. Mar 26, 2018Unusual

    ATRA

    Sold 5.2% of their holdings

    $729k18,327 shares at $39.79

    Filed Mar 27, 2018Form 4

  10. Nov 15, 2017Plan not stated

    ATRA

    Sold 0.5% of their holdings

    $21k1,604 shares at $13.36

    Filed Nov 17, 2017Form 4

10 of 34

Every transaction

Every transaction on a Form 4 or Form 5 by Haqq Christopher
TradedFiledStockRoleWhatAmountPriceValueHeld afterSource
Jul 16, 2026Jul 17, 2026ELTXOfficerAwardedStock Option (Right to Buy)64,64364,643SEC
Feb 2, 2026Feb 3, 2026ELTXOfficerAwardedStock Option (Right to Buy)50,90050,900SEC
Feb 2, 2026Feb 3, 2026ELTXOfficerAwarded25,40057,381SEC
Feb 3, 2025Feb 4, 2025ELTXOfficerAwardedStock Option (Right to Buy)44,00044,000SEC
Sep 30, 2024Oct 2, 2024ELTXOfficerAwardedStock Option (Right to Buy)28,20028,200SEC
Feb 1, 2024Feb 5, 2024ELTXOfficerAwardedStock Option (right to buy)28,20028,200SEC
Aug 11, 2021Aug 13, 2021SRZNOtherReturned to the companyClass B Ordinary Shares30,0000SEC
Aug 11, 2021Aug 13, 2021SRZNOtherAwarded30,00030,000SEC
Feb 15, 2019Feb 19, 2019ATRAEVP, R&D & Chief Scientific OfSold775$39.59$31k271,943SEC
Feb 11, 2019Feb 11, 2019ATRAEVP, R&D & Chief Scientific OfSold13,975$38.55$539k272,718SEC
Feb 6, 2019Feb 8, 2019ATRAEVP, R&D & Chief Scientific OfSold12,375$38.62$478k273,205SEC
Feb 6, 2019Feb 8, 2019ATRAEVP, R&D & Chief Scientific OfWithheld for tax1,512$38.47$58k271,693SEC
Feb 6, 2019Feb 8, 2019ATRAEVP, R&D & Chief Scientific OfAwardedEmployee Stock Option (Right to Buy)30,00030,000SEC
Feb 6, 2019Feb 8, 2019ATRAEVP, R&D & Chief Scientific OfAwarded15,000286,693SEC
Nov 15, 2018Nov 15, 2018ATRAEVP, R&D & Chief Scientific OfSold775$33.81$26k285,580SEC
Sep 26, 2018Sep 27, 2018ATRAEVP, R&D & Chief Scientific OfSold13,500$43.08$582k286,355SEC
Sep 25, 2018Sep 25, 2018ATRAEVP, R&D & Chief Scientific OfSold31,500$40.17$1.3M299,855SEC
Aug 15, 2018Aug 16, 2018ATRAEVP, R&D & Chief Scientific OfSold775$37.54$29k331,355SEC
May 15, 2018May 16, 2018ATRAEVP, R&D & Chief Scientific OfSold25,775$45.30$1.2M332,130SEC
May 15, 2018May 16, 2018ATRAEVP, R&D & Chief Scientific OfExercised or settledEmployee Stock Option (Right to Buy)25,00025,000SEC
May 15, 2018May 16, 2018ATRAEVP, R&D & Chief Scientific OfExercised options25,000$11.00$275k357,905SEC
Mar 26, 2018Mar 27, 2018ATRAEVP, R&D & Chief Scientific OfSold18,327$39.79$729k332,905SEC
Feb 15, 2018Feb 20, 2018ATRAEVP, R&D & Chief Scientific OfExercised or settledRestricted Stock Units5530SEC
Feb 15, 2018Feb 20, 2018ATRAEVP, R&D & Chief Scientific OfExercised options553351,232SEC
Feb 9, 2018Feb 12, 2018ATRAEVP, R&D & Chief Scientific OfWithheld for tax4,925$41.70$205k350,679SEC
Feb 6, 2018Feb 8, 2018ATRAEVP, R&D & Chief Scientific OfWithheld for tax4,426$35.80$158k355,604SEC
Feb 6, 2018Feb 8, 2018ATRAEVP, R&D & Chief Scientific OfAwardedEmployee Stock Option (Right to Buy)35,00035,000SEC
Feb 6, 2018Feb 8, 2018ATRAEVP, R&D & Chief Scientific OfAwarded17,500360,030SEC
Nov 15, 2017Nov 17, 2017ATRAEVP, R&D & Chief Scientific OfSold1,604$13.36$21k342,530SEC
Nov 15, 2017Nov 17, 2017ATRAEVP, R&D & Chief Scientific OfExercised or settledRestricted Stock Units829553SEC
Nov 15, 2017Nov 17, 2017ATRAEVP, R&D & Chief Scientific OfExercised options829344,134SEC
Oct 16, 2017Oct 17, 2017ATRAEVP, R&D & Chief Scientific OfSold6,000$14.35$86k343,305SEC
Sep 15, 2017Sep 18, 2017ATRAEVP, R&D & Chief Scientific OfSold6,000$15.30$92k349,305SEC
Aug 15, 2017Aug 17, 2017ATRAEVP, R&D & Chief Scientific OfSold7,604$14.75$112k355,305SEC
Aug 15, 2017Aug 17, 2017ATRAEVP, R&D & Chief Scientific OfExercised or settledRestricted Stock Units8291,382SEC
Aug 15, 2017Aug 17, 2017ATRAEVP, R&D & Chief Scientific OfExercised options829362,909SEC
Jul 17, 2017Jul 18, 2017ATRAEVP, R&D & Chief Scientific OfSold6,000$14.92$90k362,080SEC
Jun 15, 2017Jun 16, 2017ATRAEVP, R&D & Chief Scientific OfSold6,000$12.65$76k368,080SEC
May 15, 2017May 17, 2017ATRAEVP, R&D & Chief Scientific OfSold7,604$14.99$114k374,080SEC
May 15, 2017May 17, 2017ATRAEVP, R&D & Chief Scientific OfExercised or settledRestricted Stock Units8292,211SEC
May 15, 2017May 17, 2017ATRAEVP, R&D & Chief Scientific OfExercised options829381,684SEC
Apr 17, 2017Apr 19, 2017ATRAEVP, R&D & Chief Scientific OfSold6,000$17.28$104k380,855SEC
Mar 15, 2017Mar 17, 2017ATRAEVP, R&D & Chief Scientific OfSold6,000$19.60$118k386,855SEC
Feb 15, 2017Feb 16, 2017ATRAEVP, R&D & Chief Scientific OfSold7,604$15.49$118k392,855SEC
Feb 15, 2017Feb 16, 2017ATRAEVP, R&D & Chief Scientific OfExercised or settledRestricted Stock Units8293,040SEC
Feb 15, 2017Feb 16, 2017ATRAEVP, R&D & Chief Scientific OfExercised options829400,459SEC
Feb 9, 2017Feb 10, 2017ATRAEVP, R&D & Chief Scientific OfSold13,975$15.46$216k399,630SEC
Feb 6, 2017Feb 8, 2017ATRAEVP, R&D & Chief Scientific OfAwarded49,500413,605SEC
Jan 17, 2017Jan 18, 2017ATRAEVP, R&D & Chief Scientific OfSold6,000$14.27$86k364,105SEC
Dec 15, 2016Dec 15, 2016ATRAChief Medical OfficerSold6,000$15.40$92k370,105SEC
Page 1

Sales and notices (34)

Form 144 notices and Form 4 sales by Haqq Christopher
Source
Feb 15, 2019Feb 19, 2019ATRAEVP, R&D & Chief Scientific OfForm 4 sale775$31k0.3%Plan not statedSEC
Feb 11, 2019Feb 11, 2019ATRAEVP, R&D & Chief Scientific OfForm 4 sale13,975$539k4.9%Plan not statedSEC
Feb 6, 2019Feb 8, 2019ATRAEVP, R&D & Chief Scientific OfForm 4 sale12,375$478k4.3%Plan not statedSEC
Nov 15, 2018Nov 15, 2018ATRAEVP, R&D & Chief Scientific OfForm 4 sale775$26k0.3%Plan not statedSEC
Sep 26, 2018Sep 27, 2018ATRAEVP, R&D & Chief Scientific OfForm 4 sale13,500$582k4.5%Plan not statedSEC
Sep 25, 2018Sep 25, 2018ATRAEVP, R&D & Chief Scientific OfForm 4 sale31,500$1.3M9.5%UnusualSEC
Aug 15, 2018Aug 16, 2018ATRAEVP, R&D & Chief Scientific OfForm 4 sale775$29k0.2%Plan not statedSEC
May 15, 2018May 16, 2018ATRAEVP, R&D & Chief Scientific OfForm 4 sale25,775$1.2M7.2%UnusualSEC
Mar 26, 2018Mar 27, 2018ATRAEVP, R&D & Chief Scientific OfForm 4 sale18,327$729k5.2%UnusualSEC
Nov 15, 2017Nov 17, 2017ATRAEVP, R&D & Chief Scientific OfForm 4 sale1,604$21k0.5%Plan not statedSEC
Oct 16, 2017Oct 17, 2017ATRAEVP, R&D & Chief Scientific OfForm 4 sale6,000$86k1.7%Plan not statedSEC
Sep 15, 2017Sep 18, 2017ATRAEVP, R&D & Chief Scientific OfForm 4 sale6,000$92k1.7%Plan not statedSEC
Aug 15, 2017Aug 17, 2017ATRAEVP, R&D & Chief Scientific OfForm 4 sale7,604$112k2.1%Plan not statedSEC
Jul 17, 2017Jul 18, 2017ATRAEVP, R&D & Chief Scientific OfForm 4 sale6,000$90k1.6%Plan not statedSEC
Jun 15, 2017Jun 16, 2017ATRAEVP, R&D & Chief Scientific OfForm 4 sale6,000$76k1.6%Plan not statedSEC
May 15, 2017May 17, 2017ATRAEVP, R&D & Chief Scientific OfForm 4 sale7,604$114k2.0%Plan not statedSEC
Apr 17, 2017Apr 19, 2017ATRAEVP, R&D & Chief Scientific OfForm 4 sale6,000$104k1.6%Plan not statedSEC
Mar 15, 2017Mar 17, 2017ATRAEVP, R&D & Chief Scientific OfForm 4 sale6,000$118k1.5%Plan not statedSEC
Feb 15, 2017Feb 16, 2017ATRAEVP, R&D & Chief Scientific OfForm 4 sale7,604$118k1.9%UnusualSEC
Feb 9, 2017Feb 10, 2017ATRAEVP, R&D & Chief Scientific OfForm 4 sale13,975$216k3.4%UnusualSEC
Jan 17, 2017Jan 18, 2017ATRAEVP, R&D & Chief Scientific OfForm 4 sale6,000$86k1.6%Plan not statedSEC
Dec 15, 2016Dec 15, 2016ATRAChief Medical OfficerForm 4 sale6,000$92k1.6%Plan not statedSEC
Nov 21, 2016Nov 22, 2016ATRAChief Medical OfficerForm 4 sale7,068$126k1.8%Plan not statedSEC
Nov 15, 2016Nov 17, 2016ATRAChief Medical OfficerForm 4 sale1,604$32k0.4%Plan not statedSEC
Aug 15, 2016Aug 17, 2016ATRAChief Medical OfficerForm 4 sale1,346$30k0.5%Plan not statedSEC
May 16, 2016May 18, 2016ATRAChief Medical OfficerForm 4 sale1,605$25k0.5%Plan not statedSEC
Feb 16, 2016Feb 18, 2016ATRAChief Medical OfficerForm 4 sale3,208$49k1.1%Plan not statedSEC
Aug 31, 2015Sep 1, 2015ATRAChief Medical OfficerForm 4 sale5,000$210k2.0%Plan not statedSEC
Aug 17, 2015Aug 19, 2015ATRAChief Medical OfficerForm 4 sale1,604$74k0.6%Plan not statedSEC
Jul 31, 2015Aug 3, 2015ATRAChief Medical OfficerForm 4 sale2,500$139k1.0%Plan not statedSEC
Jul 15, 2015Jul 15, 2015ATRAChief Medical OfficerForm 4 sale2,500$157k1.0%Plan not statedSEC
Jul 1, 2015Jul 2, 2015ATRAChief Medical OfficerForm 4 sale2,500$129k1.0%Plan not statedSEC
Jun 15, 2015Jun 16, 2015ATRAChief Medical OfficerForm 4 sale7,500$348k2.9%Plan not statedSEC
Jun 1, 2015Jun 1, 2015ATRAChief Medical OfficerForm 4 sale2,500$104k0.9%Plan not statedSEC